BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36835048)

  • 21. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
    Liu WK; Tian XD; Yang YM
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical usefulness of plasma chromogranin a in pancreatic neuroendocrine neoplasm.
    Paik WH; Ryu JK; Song BJ; Kim J; Park JK; Kim YT; Yoon YB
    J Korean Med Sci; 2013 May; 28(5):750-4. PubMed ID: 23678268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic pancreatic neuroendocrine neoplasms: A retrospective clinicopathological and outcome analysis from a Latvian study group.
    Ptasnuka M; Truskovs A; Ozolins A; Narbuts Z; Sperga M; Plaudis H
    Front Surg; 2023; 10():1131333. PubMed ID: 37021091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms-A Single-Center Retrospective Outcome Analysis.
    Lindner K; Binte D; Hoeppner J; Wellner UF; Schulte DM; Schmid SM; Luley K; Buchmann I; Tharun L; Keck T; Gebauer J; Kulemann B
    Curr Oncol; 2021 Aug; 28(4):3071-3080. PubMed ID: 34436034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can we predict recurrence in WHO G1-G2 pancreatic neuroendocrine neoplasms? Results from a multi-institutional Spanish study.
    Ausania F; Senra Del Rio P; Gomez-Bravo MA; Martin-Perez E; Pérez-Daga JA; Dorcaratto D; González-Nicolás T; Sanchez-Cabus S; Tardio-Baiges A
    Pancreatology; 2019 Mar; 19(2):367-371. PubMed ID: 30683515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current diagnosis and treatment progress of small pancreatic neuroendocrine neoplasm].
    Jiang JL; Wu WM; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2018 Dec; 56(12):951-956. PubMed ID: 30497122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconsideration of operative indications in pancreatic neuroendocrine neoplasms.
    Abe K; Kitago M; Iwasaki E; Yagi H; Abe Y; Hasegawa Y; Hori S; Tanaka M; Nakano Y; Kitagawa Y
    World J Surg Oncol; 2022 Nov; 20(1):366. PubMed ID: 36397094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Assessment of Non-functioning Neuroendocrine Pancreatic Neoplasms as a Basis for Risk-Adapted Resection Strategies.
    Watzka FM; Meyer F; Staubitz JI; Fottner C; Schad A; Lang H; Musholt TJ
    World J Surg; 2020 Feb; 44(2):594-603. PubMed ID: 31605171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
    Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
    Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model.
    Manoharan J; Fendrich V; Di Fazio P; Bollmann C; Roth S; Joos B; Mintziras I; Albers MB; Ramaswamy A; Bertolino P; Zhang CX; Slater EP; Bartsch DK; Lopez-Lopez CL
    Neuroendocrinology; 2018; 107(3):257-266. PubMed ID: 30025403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
    Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A
    Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment options of pancreatic neuroendocrine neoplasm with liver metastasis].
    Yuan CH; Tao LY; Xiu DR
    Zhonghua Wai Ke Za Zhi; 2017 Sep; 55(9):650-654. PubMed ID: 28870048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
    Machado MC
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):145-8. PubMed ID: 22584720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion.
    Petignot S; Daly AF; Castermans E; Korpershoek E; Scagnol I; Beckers P; Dideberg V; Rohmer V; Bours V; Beckers A
    Horm Metab Res; 2020 Nov; 52(11):784-787. PubMed ID: 32521546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms.
    Haugvik SP; Gorunova L; Haugom L; Eibak AM; Gladhaug IP; Heim S; Micci F
    Oncol Rep; 2014 Sep; 32(3):906-12. PubMed ID: 25018013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic computed tomography is useful for prediction of pathological grade in pancreatic neuroendocrine neoplasm.
    Horiguchi S; Kato H; Shiraha H; Tsutsumi K; Yamamoto N; Matsumoto K; Tomoda T; Uchida D; Akimoto Y; Mizukawa S; Tanaka T; Ichimura K; Takaki A; Yagi T; Okada H
    J Gastroenterol Hepatol; 2017 Apr; 32(4):925-931. PubMed ID: 27637470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A personal experience with pancreatic and duodenal neuroendocrine tumors.
    Jordan PH
    J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.